UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

Cancer Immunology, Immunotherapy, 2021-04, Vol.70 (4), p.1089-1099

2021

Volltextzugriff (PDF)

The natural course of cutaneous melanoma

Journal of surgical oncology, 2004-07, Vol.86 (4), p.172-178

2004

Volltextzugriff (PDF)

Incisional biopsy and melanoma prognosis: Facts and controversies

Clinics in dermatology, 2010-05, Vol.28 (3), p.316-318

2010

Volltextzugriff (PDF)

Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

The lancet oncology, 2016-09, Vol.17 (9), p.1248-1260

2016

Volltextzugriff (PDF)

Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma

European journal of cancer (1990), 2023-03, Vol.182, p.77-86

2023

Volltextzugriff (PDF)

Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma

European journal of cancer (1990), 2020-01, Vol.125, p.38-45

2020

Volltextzugriff (PDF)

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma

European journal of cancer (1990), 2019-03, Vol.109, p.61-69

2019

Volltextzugriff (PDF)

Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients

European journal of cancer (1990), 2017-03, Vol.73, p.61-70

2017

Volltextzugriff (PDF)

Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage

Pigment cell and melanoma research, 2023-11, Vol.36 (6), p.512-521

2023

Volltextzugriff (PDF)

Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia

Journal of the European Academy of Dermatology and Venereology, 2024-01, Vol.38 (1), p.84-92

2024

Volltextzugriff (PDF)

Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study

Journal of the American Academy of Dermatology, 2024-04, Vol.90 (4), p.739-748

2024

Volltextzugriff (PDF)

443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011

European journal of cancer (1990), 2015-05, Vol.51 (7), p.861-868

2015

Volltextzugriff (PDF)

Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up

Journal of cancer research and clinical oncology, 2017-04, Vol.143 (4), p.703-708

2017

Volltextzugriff (PDF)

Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors

Melanoma research, 2011-12, Vol.21 (6), p.475-482

2011

Volltextzugriff (PDF)

Increased CCL17 serum levels are associated with improved survival in advanced melanoma

Cancer Immunology, Immunotherapy, 2015-09, Vol.64 (9), p.1075-1082

2015

Volltextzugriff (PDF)

Mitotic rate in primary melanoma: interobserver and intraobserver reliability, analyzed using H&E sections and immunohistochemistry

Journal der Deutschen Dermatologischen Gesellschaft, 2016-09, Vol.14 (9), p.910-915

2016

Volltextzugriff (PDF)

Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009

Melanoma research, 2011-06, Vol.21 (3), p.228-234

2011

Volltextzugriff (PDF)

Melanocytic nevi

Journal der Deutschen Dermatologischen Gesellschaft, 2011-09, Vol.9 (9), p.723-734

2011

Volltextzugriff (PDF)

An open-label, multicentre safety study of vemurafenib in patients with BRAF V600 -mutant metastatic melanoma: final analysis and a validated prognostic scoring system

European journal of cancer (1990), 2019-01, Vol.107, p.175

2019

Volltextzugriff (PDF)

Melanoma of the Nose: Prognostic Factors, Three-Dimensional Histology, and Surgical Strategies

The Laryngoscope, 2006-07, Vol.116 (7), p.1204-1211

2006

Volltextzugriff (PDF)

Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin

The American journal of surgical pathology, 1999-07, Vol.23 (7), p.822

1999

Volltextzugriff (PDF)

Problems in defining cutoff points of continuous prognostic factors: Example of tumor thickness in primary cutaneous melanoma

Journal of clinical epidemiology, 1997-11, Vol.50 (11), p.1201-1210

1997

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

KollektioneBooks on EBSCOhost

Zeitschrift / SerieJournal Of Clinical Oncology

ThemaMelanoma - Pathology

ThemaPrognosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Englisch
(27)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial

Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

The natural course of cutaneous melanoma

Incisional biopsy and melanoma prognosis: Facts and controversies

Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma

Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma

Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials

Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients

Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage

Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia

Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study

443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011

Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up

Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors

Increased CCL17 serum levels are associated with improved survival in advanced melanoma

Mitotic rate in primary melanoma: interobserver and intraobserver reliability, analyzed using H&E sections and immunohistochemistry

Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009

Melanocytic nevi

An open-label, multicentre safety study of vemurafenib in patients with BRAF V600 -mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Melanoma of the Nose: Prognostic Factors, Three-Dimensional Histology, and Surgical Strategies

Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin

Problems in defining cutoff points of continuous prognostic factors: Example of tumor thickness in primary cutaneous melanoma

Aktive Filter

Suchergebnisse filtern